Coronavirus
The latest news, research and opinion on coronavirus and covid-19, including antiviral development and delivery, pathology, and disease biochemistry.
NIH sparks concern by singling out mRNA vaccine research for added scrutiny
The Department of Health and Human Services denies mRNA research faces defunding but scientists are still worried
Classifications, racial discrimination and Covid-19
Lessons with philosophical significance for how we group people and objects
Chemists amid coronavirus five years on
Rebecca Trager catches up with four chemists to see how their working lives have changed since the start of the Covid-19 pandemic
Chemists amid coronavirus five years on: Krystle McLaughlin
An assistant chemistry professor at a small college in New York gets her career back on track, thanks to a tenure clock extension and teaching release
Chemists amid coronavirus five years on: Liang Zhang
Lockdown gave a young chemistry professor in China the space and time to consider the most worthwhile projects, and that has benefited his team
Chemists amid coronavirus five years on: Anya Gryn’ova
A computational chemist has moved from being group leader at a German research institute to an associate computational chemistry prof in the UK
Chemists amid coronavirus five years on: Lee Cronin
A University of Glasgow chemist describes how Covid-19 helped establish the principle of chemputation and spur a chemistry revolution
Forming bonds through Covid-19
How studying chemistry helped ward off loneliness during the pandemic
Moderna’s mRNA vaccine approved for RSV
US approval adds complementary option to protein-based vaccines for respiratory syncytial virus
Introduction: the coronavirus pandemic and the future
This series of Chemistry World reports is part of a forth coming e-book and hardback to be published by the Royal Society of Chemistry. The book was motivated by a desire on the part of the editors and the authors to produce a body of information on the new and deadly coronavirus about which the world was largely uninformed and for which it was totally unprepared.
Favipiravir
Originally developed to treat flu and marketed in Japan as Avigan, promising Covid-19 trial results have seen countries stockpiling this medication by the millions
Source: © StreetVJ / Shutterstock.com
EcoHealth Alliance fights back against US government funding suspension
New York-based non-profit will file documents refuting allegations about inadequate oversight of NIH-funded research in China just before the pandemic
Elevated carbon dioxide lets Sars-CoV-2 live far longer in droplets
Study explains why good ventilation lowers transmission of Covid-19
Chinese scientist who published Sars-CoV-2 genome without approval regains access to lab
Following Zhang Yongzhen and his team’s eviction from their lab, a protest appears to have forced a U-turn from authorities
New Covid-19 antiviral cuts symptoms by 1.5 days
Simnotrelvir already has emergency approval in China
Spearheading antiviral discovery with AI and open innovation
The Covid Moonshot experiment
Pharmaceuticals roundup 2023
Regulatory and pricing reforms have topped industry agendas in 2023, while weight loss drugs surged and Covid-19 therapies waned
ACE2 receptor not essential for Sars-CoV-2 infection, study shows
Fresh understanding linked to evolutionary plasticity of Covid-19 virus
mRNA vaccine pioneers win medicine Nobel prize
Katalin Karikó and Drew Weissman honoured for breakthroughs that enable the rapid development of new vaccines, including several of those used against Covid-19
Air monitor detects airborne virus particles in real time
Device that detects Sars-CoV-2 could be adapted to monitor other respiratory pathogens
Battling long Covid with drugs
Can we clean Covid from the air around us?
The human health observatory in our sewers
mRNA vaccines for Covid and beyond
Experimenting in a pandemic
2020: the year the world changed
- Previous
- Next
Glow-in-the-dark proteins offer cheap and fast diagnostic tests
Covid-19 can be detected with the sensitivity of PCR and the ease of lateral flow
Setting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
Pharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
The end of a long race?
The finishing line of the Covid-19 pandemic may be in sight, but we mustn’t stop running just yet
French inquiry censures lab that promoted hydroxychloroquine to treat Covid
Report raises awkward questions about prominent study on antimalarial conducted in Didier Raoult’s lab
Angela Russell: ‘We have to not be afraid of failing’
The medicinal chemist on thinking like a scientist and knowing where you want to go
Protective treatment for Covid-19 makes minimal impact
Limited uptake of antibody combination for vulnerable patients, while demand for antivirals seems to be slowing
Medical research charities report £260 million shortfall due to pandemic
The impact of Covid-19 on fundraising efforts sees charities slash research support
New questions raised over Sputnik Covid vaccine results point to fraudulent practices
Analysis comparing Sputnik results with five other Covid vaccines finds phase 3 trial outcome is highly improbable
Catalogues of complexity
The tangled web of fine chemicals supply frequently throws up surprises
Teaching-focused staff contribute to REF results too
But are often overlooked in celebrations of research excellence
What is the future of Covid-19 pharmaceuticals?
Firms anticipate long-term markets for prevention and treatment
UK’s non-profit vaccine manufacturing centre sold off before opening
Pharmaceutical firm Catalent buys government-backed facility near Oxford
Moderna sued over Covid-19 vaccine-related patents
Arbutus and Genevant say lipid nanoparticles that protect mRNA infringe six key patents
Living through Covid-19
Many researchers are now feeling the effects of additional emotional burdens
Explainer: How do the Covid vaccines measure up against each other and omicron?
Looking at how the evidence stacks up for vaccines against variants and how their performance holds up over time
The shadow of drug resistance
Why do some medicines stop working, and can we avoid it for Covid-19 antivirals?
The conference conundrum
Following the Covid-19 pandemic, is it time to rethink events for good?